Image

Global Kaposi Sarcoma Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Kaposi Sarcoma Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Kaposi Sarcoma Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 140.08 USD Million
Diagram Market Size (Forecast Year) USD 200.70 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Kaposi Sarcoma Market, By Type (Epidemic (AIDS Associated) Kaposi Sarcoma, Classic (Mediterranean) Kaposi Sarcoma, Endemic (African) Kaposi Sarcoma, Latrogenic (Transplant-Related) Kaposi Sarcoma), Treatment (HAART, Radiation Therapy, Surgery, Cryosurgery, Chemotherapy, Biological Therapy), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Kaposi Sarcoma Market

Kaposi Sarcoma Market Analysis and Size

With the increasing prevalence of kaposi sarcoma and the growing number of patients undergoing organ transplantation procedures, patients undergoing organ transplantations are more susceptible to Kaposi sarcoma. Patients having weakened immune systems by acquired immune deficiency syndrome (AIDS) disease or drugs prescribed post-organ transplantation surgery are highly vulnerable to HHV-8. Organ transplant patients are majorly prescribed immunosuppressive agents to avoid their bodies from rejecting the graft, increasing their susceptibility to kaposi sarcoma-associated herpesvirus (KSHV) infection. The increasing use of these agents increases these patients' risk rate by over 100 times more than the general population.

Data Bridge Market Research analyses a growth rate in the kaposi sarcoma market in the forecast period 2023-2020. The expected CAGR of the kaposi sarcoma market tends to be around 4.6% in the mentioned forecast period. The market was valued at USD 140.08 million in 2022 and would grow to USD 200.7 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Kaposi Sarcoma Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Epidemic (AIDS Associated) Kaposi Sarcoma, Classic (Mediterranean) Kaposi Sarcoma, Endemic (African) Kaposi Sarcoma, Latrogenic (Transplant-Related) Kaposi Sarcoma), Treatment (HAART, Radiation Therapy, Surgery, Cryosurgery, Chemotherapy, Biological Therapy), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Johnson & Johnson Private Limited (U.S.), Abbott (U.S.), AbbVie Inc. (U.S.), Bausch Health Companies Inc. (Canada), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Hikma Pharmaceuticals PLC (U.K.), Amneal Pharmaceuticals LLC. (U.S.), Pfizer Inc (U.S.), Mylan N.V. (U.S.), Bristol-Myers Squibb Company (U.S.), GSK plc. (U.K.), Bayer AG (Germany)

Market Opportunities

  • Increased Research and Development
  • Rising Healthcare Awareness

Market Definition

Kaposi sarcoma is a kind of malignant tumor that is majorly associated with skin, mucous membranes, lymph nodes, and other organs. These patches or lesions are usually red or purple. They consist of cancer cells, blood vessels, and blood cells. Human herpesvirus-8 (HHV-8) is chiefly found in the lesion of all patients who are suffering from kaposi sarcoma.

Kaposi Sarcoma Market Dynamics

Drivers

  • Increased Rate of Transplantations

According to the records of the Global Observatory on Donation and Transplantation, 1 39,024 organs were transplanted globally in 2017 in total, wherein 90,306 (Kidney), 32,348 (Liver), 7,881 (Heart), 6,084 (Lung), 2,243 (Pancreas), 162 (Small Bowel) transplantations took place. Therefore, these transplantations make the patient more vulnerable to this sarcoma. Thus, it boosts the market growth.

  • Growing Strategic Collaborations by Market Players

Lately, several market strategies have been major changes, such as product developments, mergers, and acquisitions. For instance, in 2019, The U.S. FDA granted breakthrough therapy designation to Celgene's pomalidomide (Pomalyst) for the treatment of patients with HIV-positive kaposi sarcoma who have received prior chemotherapy, combined with patients with HIV-negative kaposi sarcoma. This increases the growth of the market.

Opportunities

  • Increasing Demand for HAART

Rising demand for antiretroviral therapies leads to patients' faster recovery. For individuals having Epidemic (AIDS-associated) kaposi sarcoma, antiretroviral treatment for HIV or AIDS is generally used before other therapies for the treatment of the tumor and decreasing the symptoms. HAART is preferred as individual therapy or chemotherapy based on the disease's spread and the symptoms of the patients. Therefore, this treatment procedure is greatly boosting the growth of the market.

  • Increasing Healthcare Awareness

Health awareness amongst the population is growing, which results in the expectation that drugs boost market growth. The innovative launches in medications for handling squamous cell carcinoma are projected to prompt the market simultaneously. For instance, in September 2014, F. Hoffmann-La Roche Ltd. came up with a new Global Access Program for HIV viral load testing partnered with United Nations Program on HIV/AIDS (UNAIDS), the Clinton Health Access Initiative, the President's Emergency Plan for AIDS Relief, and the Global Fund. The program was completely focused on HIV viral load testing. This creates more opportunities in the market.

Restraints/Challenges

  • Shortage In Supply Of Drugs Due To Wide Demand-Supply Gap  

Drug shortage is a public issue affecting low, middle, and high-income countries. Numerous countries have developed several strategies to overcome the problem, while the problem is increasing, affecting the whole world. Different types of drugs, such as essential life-saving drugs, antimicrobial drugs, analgesics, oncology medicines, opioids, radiopharmaceutical, and parenteral products, cardiovascular drugs, are liable to the shortage.

  • High Cost

The enormous expenditure on treatment methods hinder the market growth. For instance, according to the data published by Monash University Malaysia in 2016, the prices of major drugs that are used for the treatment of kaposi sarcoma, such as liposomal doxorubicin, liposomal daunorubicin, or paclitaxel along with HAART, are growing significantly, making them unaffordable for middle- and lower-income group patients.

This kaposi sarcoma market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the kaposi sarcoma market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Kaposi Sarcoma Market Scope

The kaposi sarcoma market is segmented on the basis of type, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Epidemic (AIDS Associated) Kaposi Sarcoma
  • Classic (Mediterranean) Kaposi Sarcoma
  • Endemic (African) Kaposi Sarcoma
  • Latrogenic (Transplant-Related) Kaposi Sarcoma)

Treatment

  • HAART
  • Radiation Therapy
  • Surgery
  • Cryosurgery
  • Chemotherapy
  • Biological Therapy  

End-Users

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Kaposi Sarcoma Market Regional Analysis/Insights

The kaposi sarcoma market is analyzed and market size insights and trends are provided by type, treatment, distribution channel and end-user as referenced above.

The major countries covered in the kaposi sarcoma market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth because of the increase in the number of Kaposi's sarcoma patients, along with the rise in organ transplants and the intake of immune suppressants.  

Asia-Pacific dominates the market due to the increased prevalence of organ transplantation and such therapies in the region. For instance, as per the Global Observatory On Donation And Transplantation, 1,39,024 organs were transplanted worldwide in 2017, which was quite high thus increasing the market share.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Kaposi Sarcoma Market Share Analysis

The kaposi sarcoma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to kaposi sarcoma market.

Key players operating in the kaposi sarcoma market include:

  • Johnson & Johnson Private Limited (U.S.)
  • Abbott (U.S.)
  • AbbVie Inc. (U.S.)
  • Bausch Health Companies Inc. (Canada)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Aurobindo Pharma (India)
  • Lupin (India)
  • Hikma Pharmaceuticals PLC (U.K.)
  • Amneal Pharmaceuticals LLC. (U.S.)
  • Pfizer Inc (U.S.)
  • Mylan N.V. (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • Bayer AG (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Kaposi Sarcoma Market is projected to grow at a CAGR of 4.6% during the forecast period by 2030.
The future market value of the Kaposi Sarcoma Market is expected to reach USD 200.7 million by 2030.
The major players in the Kaposi Sarcoma Market are ohnson & Johnson Private Limited (U.S.), Abbott (U.S.), AbbVie Inc. (U.S.), Bausch Health Companies Inc. (Canada), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), etc.
The countries covered in the Kaposi Sarcoma Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials